Beau R. Webber
- Molecular Biology top 5%
- Oncology top 5%
- Genetics top 5%
- Immunology top 10%
- Cell Biology top 5%
- Co-authors
- Branden S. MoriarityWalker S. LahrMitchell G. KluesnerJakub TolarMark J. OsbornAmber McElroyJuan E. AbrahanteJohn Garbe
- Topics
- CRISPR and Genetic Engineering (25 papers)CAR-T cell therapy research (23 papers)Immune Cell Function and Interaction (12 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Beau R. Webber
50 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Molecular Biology 1.4k
- Oncology 526
- Genetics 459
- Immunology 296
- Cell Biology 234
Countries citing papers authored by Beau R. Webber
This map shows the geographic impact of Beau R. Webber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beau R. Webber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beau R. Webber more than expected).
Fields of papers citing papers by Beau R. Webber
This network shows the impact of papers produced by Beau R. Webber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beau R. Webber. The network helps show where Beau R. Webber may publish in the future.
Co-authorship network of co-authors of Beau R. Webber
This figure shows the co-authorship network connecting the top 25 collaborators of Beau R. Webber. A scholar is included among the top collaborators of Beau R. Webber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beau R. Webber. Beau R. Webber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 7 | |
| 6 | 6 | |
| 7 | 11 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 90 | |
| 11 | 74 | |
| 12 | 75 | |
| 13 | 139 | |
| 14 | 62 | |
| 15 | 64 | |
| 16 | 29 | |
| 17 | 26 | |
| 18 | 9 | |
| 19 | 91 | |
| 20 | 16 |
About Beau R. Webber
Beau R. Webber is a scholar working on Oncology, Immunology and Business and International Management, having authored 55 papers that have together received 1.9k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (25 papers), CAR-T cell therapy research (23 papers) and Immune Cell Function and Interaction (12 papers). The work is most often cited by research in Business and International Management (72 citations), Aging (57 citations) and Molecular Biology (1.4k citations). Beau R. Webber has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Branden S. Moriarity, Walker S. Lahr, Mitchell G. Kluesner, Jakub Tolar, Mark J. Osborn, Amber McElroy, Juan E. Abrahante, John Garbe, Derek Nedveck and Bruce R. Blazar. Their work appears in journals such as Nature Communications, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.